Akanda EBITDA per osake

Mitä Akanda tekee? Akanda Corp, listed under ticker AKAN with ISIN CA00971M6018, is a company based in New Romney, United Kingdom, operating within the Health Care sector, specifically in Pharmaceuticals. The company has 46 employees and had its IPO on March 15, 2022. Its website is https://akandacorp.com/. Akanda Corp operates through three segments: cultivation, distribution, and corporate. The cultivation segment focuses on the cultivation of medical cannabis and medical cannabis biomass. The distribution segment handles the sale and distribution of medical cannabis products. The company's portfolio includes Holigen, a Portugal-based cultivator, manufacturer, and distributor, and CanMart, a United Kingdom-based fully licensed pharmaceutical importer and distributor that supplies pharmacies and clinics in the UK. Holigen operates a 20,000 square foot indoor facility near Lisbon in Sintra, dedicated to cultivating high-tetrahydrocannabinol (THC) cannabis. The company's supply chain involves Cansativa Group, an importer and distributor of medical cannabis in Europe, and Cellen Life Sciences Leva Clinic, a fully digital pain clinic in the United Kingdom. Akanda on yksi Eurpooliin suosituimmista yhtiöistä.